DARLING INGREDIENTS INC.
DAROther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY26 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $6.14B | $5.72B | $6.79B | $6.53B | $3.57B | $852.8M |
| Operating income | $273.4M | $468.2M | $949.7M | $1.03B | $430.9M | $122.8M |
| Net income | $62.8M | $278.9M | $647.7M | $737.7M | $296.8M | $85.5M |
| Total assets | $10.30B | $10.07B | $11.06B | $9.20B | $5.61B | — |
| Total liabilities | $5.49B | $5.61B | $6.37B | $5.31B | $2.66B | — |
| Equity | $4.74B | $4.38B | $4.61B | $3.81B | $2.89B | — |
| EPS (diluted) | $0.39 | $1.73 | $3.99 | $4.49 | $1.78 | $0.51 |
| Shares out. | 158.6M | 159.6M | 159.9M | 161.1M | 162.6M | 163.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2026- Operating margin
- 4.5%
- Net margin
- 1.0%
- Return on equity
- 1.3%
- Return on assets
- 0.6%
- Return on capital (ROCE)
- 3.0%
- Liabilities / assets
- 53.3%
- Debt / equity
- 1.16×
- Book value / share
- $29.87
- Revenue growth (YoY)
- 7.4%
- Net income growth (YoY)
- −77.5%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2026- Altman Z″ (distress)
- 2.70safe
- Accruals / assets
- −9.7%clean
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 5 good- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Dimensional Fund Advisors LpPassive (13G)Jan 21, 2026
- Gates Capital Management, Inc.Passive (13G)Aug 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Schroder SorenDirector | May 7, 2026 | Grant | 2,650 | $0.00 |
| Stoffel KurtDirector | May 7, 2026 | Grant | 2,650 | $0.00 |
| Hill Randy LDirector | May 7, 2026 | Grant | 2,650 | $0.00 |
| Guimaraes EndersonDirector | May 7, 2026 | Grant | 2,650 | $0.00 |
| Goodspeed LindaDirector | May 7, 2026 | Grant | 2,650 | $0.00 |
| Clark Celeste A.Director | May 7, 2026 | Grant | 2,650 | $0.00 |
| Barden LarryDirector | May 7, 2026 | Grant | 2,650 | $0.00 |
| Aspell Robert PatrickDirector | May 7, 2026 | Grant | 2,650 | $0.00 |
| Adair Charles LDirector | May 7, 2026 | Grant | 2,650 | $0.00 |
| Manzi JosephOfficer — Chief Accounting Officer | May 1, 2026 | Sell | 3,000 | $63.89 |
| Finnimore Mark JosephOfficer — EVP Canada & N America Spec | Mar 9, 2026 | Grant | 2,079 | $0.00 |
| Colpaert JeroenOfficer — EVP Rousselot | Mar 9, 2026 | Grant | 9,252 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 6.6M | 2.5 | +15.5% |
| Apr 30, 2026 | 5.8M | 2.0 | -16.1% |
| Apr 15, 2026 | 6.9M | 2.1 | +5.3% |
| Mar 31, 2026 | 6.5M | 1.8 | -2.1% |
| Mar 13, 2026 | 6.7M | 2.1 | -1.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMay 11, 2026
- Shareholder voteMay 8, 2026
- Results of operations · Regulation FD disclosureApr 30, 2026
- Director / officer changeFeb 25, 2026
- Results of operationsFeb 11, 2026
- Results of operationsJan 29, 2026
- Regulation FD disclosureDec 10, 2025
- Director / officer changeNov 10, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (4)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.